| Acute exacerbations of idiopathic pulmonary fibrosis HR Collard, BB Moore, KR Flaherty, KK Brown, RJ Kaner, TE King Jr, ... American journal of respiratory and critical care medicine 176 (7), 636-643, 2007 | 1353 | 2007 |
| A placebo-controlled randomized trial of warfarin in idiopathic pulmonary fibrosis I Noth, KJ Anstrom, SB Calvert, J De Andrade, KR Flaherty, C Glazer, ... American journal of respiratory and critical care medicine 186 (1), 88-95, 2012 | 549 | 2012 |
| Nintedanib in patients with progressive fibrosing interstitial lung diseases—subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised … AU Wells, KR Flaherty, KK Brown, Y Inoue, A Devaraj, L Richeldi, T Moua, ... The lancet Respiratory medicine 8 (5), 453-460, 2020 | 450 | 2020 |
| Lung overexpression of the vascular endothelial growth factor gene induces pulmonary edema RJ Kaner, JV Ladetto, R Singh, N Fukuda, MA Matthay, RG Crystal American Journal of Respiratory Cell and Molecular Biology 22 (6), 657-664, 2000 | 341 | 2000 |
| Frequency of exacerbations in patients with chronic obstructive pulmonary disease: an analysis of the SPIROMICS cohort MLK Han, PM Quibrera, EE Carretta, RG Barr, ER Bleecker, RP Bowler, ... The Lancet Respiratory Medicine 5 (8), 619-626, 2017 | 290 | 2017 |
| Airway epithelial CFTR mRNA expression in cystic fibrosis patients after repetitive administration of a recombinant adenovirus BG Harvey, PL Leopold, NR Hackett, TM Grasso, PM Williams, AL Tucker, ... The Journal of clinical investigation 104 (9), 1245-1255, 1999 | 278 | 1999 |
| Association of sputum and blood eosinophil concentrations with clinical measures of COPD severity: an analysis of the SPIROMICS cohort AT Hastie, FJ Martinez, JL Curtis, CM Doerschuk, NN Hansel, ... The Lancet Respiratory Medicine 5 (12), 956-967, 2017 | 267 | 2017 |
| Efficacy of simtuzumab versus placebo in patients with idiopathic pulmonary fibrosis: a randomised, double-blind, controlled, phase 2 trial G Raghu, KK Brown, HR Collard, V Cottin, KF Gibson, RJ Kaner, ... The Lancet Respiratory Medicine 5 (1), 22-32, 2017 | 257 | 2017 |
| Fibroblast growth factor receptor is a portal of cellular entry for herpes simplex virus type 1 RJ Kaner, A Baird, A Mansukhani, C Basilico, BD Summers, ... Science 248 (4961), 1410-1413, 1990 | 185 | 1990 |
| Compartmentalization of vascular endothelial growth factor to the epithelial surface of the human lung RJ Kaner, RG Crystal Molecular Medicine 7, 240-246, 2001 | 175 | 2001 |
| Altered lung biology of healthy never smokers following acute inhalation of E-cigarettes MR Staudt, J Salit, RJ Kaner, C Hollmann, RG Crystal Respiratory research 19, 1-10, 2018 | 158 | 2018 |
| Metoprolol for the prevention of acute exacerbations of COPD MT Dransfield, H Voelker, SP Bhatt, K Brenner, R Casaburi, CE Come, ... New England Journal of Medicine 381 (24), 2304-2314, 2019 | 156 | 2019 |
| Hypoxia upregulates VEGF expression in alveolar epithelial cells in vitro and in vivo I Pham, T Uchida, C Planes, LB Ware, R Kaner, MA Matthay, C Clerici American Journal of Physiology-Lung Cellular and Molecular Physiology 283 (5 …, 2002 | 155 | 2002 |
| Risk of COPD with obstruction in active smokers with normal spirometry and reduced diffusion capacity BG Harvey, Y Strulovici-Barel, RJ Kaner, A Sanders, TL Vincent, ... European Respiratory Journal 46 (6), 1589-1597, 2015 | 125 | 2015 |
| Mast cells: a pivotal role in pulmonary fibrosis A Veerappan, NJ O'Connor, J Brazin, AC Reid, A Jung, D McGee, ... DNA and cell biology 32 (4), 206-218, 2013 | 108 | 2013 |
| Airway Basal stem/progenitor cells have diminished capacity to regenerate airway epithelium in chronic obstructive pulmonary disease MR Staudt, LJ Buro-Auriemma, MS Walters, J Salit, T Vincent, ... American journal of respiratory and critical care medicine 190 (8), 955-958, 2014 | 104 | 2014 |
| Common genetic polymorphisms influence blood biomarker measurements in COPD W Sun, K Kechris, S Jacobson, MB Drummond, GA Hawkins, J Yang, ... PLoS genetics 12 (8), e1006011, 2016 | 102 | 2016 |
| Analysis of risk factors for local delivery of low-and intermediate-dose adenovirus gene transfer vectors to individuals with a spectrum of comorbid conditions RG Crystal, BG Harvey, JP Wisnivesky, KA O'Donoghue, KW Chu, ... Human gene therapy 13 (1), 65-100, 2002 | 101 | 2002 |
| Modification of the Genetic Program of Human Alveolar Macrophages by Adenovirus Vectors In Vitro Is Feasible but Inefficient, Limited in Part by the Low Level of … RJ Kaner, S Worgall, PL Leopold, E Stolze, E Milano, C Hidaka, ... American Journal of Respiratory Cell and Molecular Biology 20 (3), 361-370, 1999 | 99 | 1999 |
| Smoking accelerates aging of the small airway epithelium MS Walters, BP De, J Salit, LJ Buro-Auriemma, T Wilson, AM Rogalski, ... Respiratory research 15, 1-13, 2014 | 98 | 2014 |
